[
    [
        {
            "time": "",
            "original_text": "药明、康龙、泰格、昭衍4家“A+H”股CRO业绩大涨，中国企业增长超越全球TOP5",
            "features": {
                "keywords": [
                    "药明",
                    "康龙",
                    "泰格",
                    "昭衍",
                    "CRO",
                    "业绩",
                    "增长",
                    "全球TOP5"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明、康龙、泰格、昭衍4家“A+H”股CRO业绩大涨，中国企业增长超越全球TOP5",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股走势分化，健康元、凯莱英、海正药业、泰格医药强势上扬",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "健康元",
                    "凯莱英",
                    "海正药业",
                    "泰格医药",
                    "强势上扬"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "高瓴概念股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股走势分化，健康元、凯莱英、海正药业、泰格医药强势上扬",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "2021国际护士节：用爱的羽翼呵护生命",
            "features": {
                "keywords": [
                    "国际护士节",
                    "医护",
                    "生命"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "2021国际护士节：用爱的羽翼呵护生命",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 2,
                "Impact": 1,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 1,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "医药行业2020年年报＆2021Q1季报小结及前瞻：业绩恢复强劲 高景气赛道表现亮眼",
            "features": {
                "keywords": [
                    "医药行业",
                    "年报",
                    "季报",
                    "业绩恢复",
                    "高景气赛道"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2020年年报＆2021Q1季报小结及前瞻：业绩恢复强劲 高景气赛道表现亮眼",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "中泰证券：国内CRO/CDMO行业全面恢复，把握具备长期成长性的板块优质公司",
            "features": {
                "keywords": [
                    "中泰证券",
                    "CRO",
                    "CDMO",
                    "全面恢复",
                    "长期成长性",
                    "优质公司"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO/CDMO行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中泰证券：国内CRO/CDMO行业全面恢复，把握具备长期成长性的板块优质公司",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]